Table 2: Pooled proportion of chronic clinical comorbidities in COVID-19 patients.

Morbidities

Crude Proportion (N=2028)

Pooled Proportion

n (%)

95% CI

Proportion

95% CI

p-value

Heterogeneity I2 (p-Value)

Hypertension (HTN)

350 (17.26)

15.64-18.97

0.15

0.09-0.21

0.001

93.24 (0.001)

Diabetes Mellitus (DM)

205 (10.11)

8.33-11.50

0.11

0.08-0.14

0.001

65.28 (0.001)

Cardiovascular Disease (CVD)*

97 (4.78)

3.90-5.80

0.06

0.03-0.08

0.001

75.63 (0.001)

Cerebrovascular Disease*

71 (3.50)

2.74-4.40

0.03

0.01-0.04

0.001

88.35 (0.001)

Chronic Lung Disease*

44 (2.17)

1.58-2.90

0.02

0.01-0.03

0.001

48.92 (0.034)

Chronic Liver Disease

30 (1.48)

1.00-2.11

NA

Malignancy

27 (1.33)

0.90-1.93

NA

Chronic Kidney Disease*

17 (0.84)

0.49-1.34

NA

Hepatitis B

23 (1.13)

0.72-1.70

NA

Digestive System Disorders*

18 (0.89)

0.53-1.40

NA

Endocrine System Disorders*

15 (0.74)

0.41-1.21

NA

Nervous System*

8 (0.40)

0.20-0.78

NA

Immunosuppression*

2 (0.10)

0.01-0.36

NA

Rheumatologic Disorders*

1 (0.05)

0.00-0.30

NA

Malnutrition

1 (0.05)

0.00-0.30

NA

Others

22 (1.08)

0.70-1.70

NA